|
December 6, 2016
|
Highlights from ASH |
|
Find out about the latest treatment advances and promising signs for the future. Read more. |
|
Better health IT and better institutional practices are necessary to leverage EHRs for quality of care. Read more. |
|
Novel immunotherapy treatments are showing promise for patients with acute lymphoblastic leukemia, but they can come with risks. Read more. |
|
|
We welcome your feedback!
Please send your comments to:
Aubrey Westgate
Executive Editor
Managed Healthcare Executive
[email protected] |
DISCLAIMER:
This information has been independently developed and provided by the editors of Managed Healthcare Executive. The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. These articles may discuss regimens that have not been approved by the FDA. For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular. |
|
